Company Description
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer.
The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development.
In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring.
The company was incorporated in 2015 and is headquartered in Menlo Park, California.
| Country | United States |
| Founded | 2016 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 910 |
| CEO | Joshua Ofman |
Contact Details
Address: 1525 O’Brien Drive Menlo Park, California 94025 United States | |
| Phone | 833 694 2553 |
| Website | grail.com |
Stock Details
| Ticker Symbol | GRAL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001699031 |
| CUSIP Number | 38902N103 |
| ISIN Number | US3847471014 |
| Employer ID | 86-3673636 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Robert P. Ragusa | Advisor |
| Paul Ciccolella | Senior Vice President of Global Development and Operations |
| Abram Barth J.D., M.P.H. | Chief Legal Officer and Corporate Secretary |
| Alison Highlander | Senior Vice President of Human Resources and Head of People Team |
| Dr. Satnam Alag Ph.D. | Senior Vice President of Software Engineering and Chief Security Officer |
| Dr. Eric T. Fung M.D., Ph.D. | Senior Vice President of Clinical Development |
| Erin Polak | Senior Vice President of Government Affairs, Policy, and Alliance Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 22, 2026 | 8-K | Current Report |
| Jun 3, 2026 | 144 | Filing |
| Jun 1, 2026 | 8-K | Current Report |
| May 15, 2026 | SCHEDULE 13G/A | Filing |
| May 11, 2026 | SCHEDULE 13G/A | Filing |
| May 7, 2026 | 10-Q | Quarterly Report |
| May 5, 2026 | 8-K | Current Report |
| Apr 28, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 28, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 6, 2026 | 144 | Filing |